With routine check-ups, healthy habits, and community support, people living with HIV can protect their heart, manage weight, ...

In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...

Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Students can schedule appointments via MySHR to consult with a provider and receive the recently FDA-approved twice-per-year ...

Among adults with controlled HIV, switching from DTG/3TC to BIC/FTC/TAF did not significantly alter systemic inflammation and metabolic parameters.

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.

South Africa has taken a major step forward in expanding its HIV-prevention toolbox, with the Department of Health confirming that the National Essential Medicines List Committee (NEMLC) has approved ...

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, was found to be non-inferior to Gilead’s (GILD) once-daily HIV pill Biktarvy ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...